MRI study of the brain's waste-clearing system in Parkinson's disease
Part of Brain & nervous system clinical trials.
This study uses a special MRI technique to look at the brain's waste-clearing system (called the glymphatic system) in people with Parkinson's disease. It aims to understand how this system works, which could help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease by a doctor.
- You are able to lie still inside an MRI scanner for the scan.
- Your Parkinson's symptoms improve with dopamine medications (like levodopa).
- Your Parkinson's disease is not caused by other conditions like stroke, head injury, or certain drugs.
- You do not have diabetes or end-stage kidney disease.
- You have no metal implants or other reasons that would make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to understand Parkinson's disease. It compares people with Parkinson's to healthy volunteers to learn how the brain changes.
This study uses a special 7‑Tesla MRI brain scan to measure tiny chemical (metabolite) differences in specific deep brain areas. It compares newly diagnosed, early-stage Parkinson’s patients who are not on Parkinson medication with healthy volunteers.
This study uses a special PET scan to look for signs of brain inflammation in people with Parkinson's disease. It aims to understand how inflammation relates to Parkinson's and may help in developing new treatments.
This study looks for early signs of nerve cell damage in the brain using a powerful MRI scanner. It may help better understand Parkinson's disease and similar conditions, which could lead to earlier diagnosis in the future.
This study uses a special PET scan to look at a protein in the brain that is linked to certain movement and memory disorders. It aims to improve diagnosis of these conditions.
This study uses MRI scans to look at dopamine signals in the brain. The goal is to understand how Parkinson's affects these signals.
Hear when a new Glymphatic System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.